WGS241115C50000
- 34.30
- +23.50+217.59%
GeneDx Holdings Newsroom
Wells Fargo Maintains GeneDx Holdings(WGS.US) With Hold Rating, Raises Target Price to $75
TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $75
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $95
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $70
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $70
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Announces Target Price $70
GeneDx Hldgs Analyst Ratings
Goldman Sachs Maintains Neutral on GeneDx Hldgs, Raises Price Target to $54
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating
GeneDx Holdings Initiated at Equal-Weight by Wells Fargo
Craig-Hallum Issues a Buy Rating on GeneDx Holdings (WGS)
GeneDx Holdings Price Target Raised to $45.00/Share From $35.00 by BTIG
GeneDx Hldgs Analyst Ratings
Goldman Sachs Maintains Neutral on GeneDx Hldgs, Raises Price Target to $32
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $46
Craig-Hallum Remains a Buy on GeneDx Holdings (WGS)
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $45
TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $50
Buy Rating Affirmed: GeneDx Holdings' Financial Growth and Promising Outlook Propel Stock's Upward Trajectory